Investigation of a Thromboxane A(2) Receptor–Based Vaccine for Managing Thrombogenesis

BACKGROUND: Despite the well‐established role for the thromboxane A(2) receptor (TPR) in the development of thrombotic disorders, none of the antagonists developed to date has been approved for clinical use. To this end, we have previously shown that an antibody targeted against TPR's ligand‐bi...

Descripción completa

Detalles Bibliográficos
Autores principales: Alshbool, Fatima Z., Karim, Zubair A., Espinosa, Enma V. Paez, Lin, Olivia A., Khasawneh, Fadi T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6064912/
https://www.ncbi.nlm.nih.gov/pubmed/29936414
http://dx.doi.org/10.1161/JAHA.118.009139

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6064912/
https://www.ncbi.nlm.nih.gov/pubmed/29936414
http://dx.doi.org/10.1161/JAHA.118.009139

Ejemplares similares